| Company Name | Date | Purpose |
|
Aptus Pharma
|
24-Mar-26
| Aptus Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve This is to inform you that meeting of the Board of Directors of the Company will be held on Tuesday March 24 2026 at Shri 1st Floor Opp Satyasai Heart Hospital Narayan Nagar Kalawad Road Kankot Rajkot Gujarat India 360005 to consider inter alia a proposal for:
1. Increase in Authorized Share Capital subject to approval of members of the Company.
2. Consideration and recommendation of Bonus Equity Shares subject to approval of Members of the Company.
Trading Window for dealing in the securities of the Company for all the Designated Persons and their immediate relatives will remain closed with effect from Wednesday 18th March 2026 Thursday March 26 2026 (both days inclusive) for aforesaid consideration/recommendation of the Board of Directors of the Company. |
|
Ashapura Minech.
|
24-Mar-26
| Ashapura Minechem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve To consider frame and if thought fit to approve the formulation of Employee Stock Option Plan subject to the approval of shareholders and the matters incidental thereto. |
|
Dev Accele.
|
24-Mar-26
| Dev Accelerator Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve the agenda items as per the attached intimation. |
|
Diamines & Chem.
|
24-Mar-26
| Diamines & Chemicals Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve conversion of warrants into Equity shares of the Company & exercise option by Warrant holders on preferential basis and to transact such other businesses as may be required. |
|
DRA Consultants
|
24-Mar-26
| DRA Consultants Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/03/2026 inter alia to consider and approve 1. Review of Business Operations of the Company. 2. Any other matter with the permission of the Chair. |
| Prev | Next |